Home Home Home Inbox Home Search

Event

Exacerbations, Health Resource Utilization, and Costs Among Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease (COPD) Treated with Nebulized Arformoterol Following a Respiratory Event [Board No. P1402]

Location: Board no. P1402
Session Type: Thematic Poster Session
Tuesday
May
22
11:15 AM
1:00 PM

Speaker(s)/Author(s)

Vaidyanathan Ganapathy

PhD
Sunovion Pharmaceuticals;Sunovion Pharmaceuticals Inc.

Bartolome R. Celli

MD
Brigham and Women's Hospital;Brigham and Women's Hospital, Harvard Medical School;Harvard Medical School;Pulmonary Division

Zhun Xu

PhD
University of California San Diego

Todd P. Gilmer

PhD
University of California San Diego

Soojin Cho-Reyes

PhD
Advance Health Solutions, LLC

Maryam Navaie

DrPH, MBA
Advance Health Solutions, LLC

View Abstract

Exacerbations, Health Resource Utilization, and Costs Among Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease (COPD) Treated with Nebulized Arformoterol Following a Respiratory Event

Parent Sessions

  • C42 - CONTEMPORARY TOPICS IN COPD
    05-22-2018 9:15 AM - 4:15 PM
    • Home Home Home Inbox Home Search